A method for preparing a hair-nourishing and hair-strengthening vitamin B complex
By optimizing the preparation process parameters of Gawazhishixuniz pills and establishing a method for determining gallic acid content, the problems of unclear preparation process parameters and insufficient quality control were solved, achieving product quality stability and controllability, making it suitable for industrial production.
Patent Information
- Application Number
- CN202611501364.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-24
- Publication Date
- 2026-11-10
AI Technical Summary
The existing preparation process parameters for Gawazhisixiuniz pills are unclear, making it difficult to guarantee the stability and uniformity of product quality. There is a lack of quantitative control over active ingredients such as gallic acid, and research on traditional honey pill dosage form processes is insufficient.
By optimizing key process parameters such as the ratio of medicinal powder to refined honey, honey temperature, drying time, and drying temperature through single-factor and orthogonal experiments, a high-performance liquid chromatography method was established to determine the gallic acid content, thereby determining the optimal preparation process and achieving quality control.
The preparation process parameters were clarified, which improved the stability and controllability of product quality, ensured the accurate control of gallic acid content, and made it suitable for large-scale industrial production.
Smart Images

Figure CN123059136A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical preparation technology, and more specifically, to a method for preparing a hair-nourishing and hair-strengthening medicine. Background Technology
[0002] Jiawarixi Xiunizi Wan is a traditional honey pill made from medicinal herbs commonly used by the Uyghur people. It is listed in the "Standards for Preparations of Uyghur Medical Institutions in Xinjiang Uyghur Autonomous Region," standard number MZJ-W-0088-2013. Its prescription consists of four herbs: 40g of black cumin seeds, 40g of Terminalia chebula pulp, 80g of dried ginger, and 80g of Ashoka fruit. Its functions and indications are to warm the stomach, strengthen hair, and darken hair; it is used for stomach cold, decreased appetite, and premature graying of hair. The dosage is 3-5g orally twice a day.
[0003] In the existing technology, the preparation method of Jiavazhixixunizi pills is as follows: the above four medicinal materials are pulverized into fine powder, sieved, mixed evenly, an appropriate amount of refined honey is added, mixed evenly, made into pills, and dried. This quality standard only specifies a very brief preparation process and does not clearly specify many key process parameters. Specifically, regarding the ratio of medicinal powder to refined honey, it only states "add an appropriate amount of refined honey" without giving a specific ratio range; regarding the temperature of mixing the honey and medicinal powder, it does not specify the temperature control requirements when mixing the honey and medicinal powder; regarding the drying time and drying temperature, it only vaguely states "drying" without specifying the specific drying time and temperature parameters.
[0004] Furthermore, existing quality standards only include items related to appearance, identification, and routine testing (moisture content, weight variation, dissolution time, microbial limits, etc.), without establishing any content determination items, and lack quantitative control methods for active ingredients or indicator components. Terminalia chebula pulp is an important component of the prescription, rich in gallic acid and other tannin-like active ingredients, but existing standards do not control its content in any way.
[0005] The aforementioned existing technologies have the following problems and shortcomings: First, the preparation process parameters are unclear, making it difficult to guarantee product quality stability. Existing quality standards only specify a vague step: "Pulverize the above four ingredients into a fine powder, sieve, mix thoroughly, add an appropriate amount of refined honey, mix thoroughly, form into pills, and dry to obtain the final product." Key process parameters such as the ratio of medicinal powder to refined honey, the temperature of the honey mixture, drying time, and drying temperature are not clearly defined. Due to the lack of quantitative standards for these key process parameters, there may be significant differences in quality indicators such as hardness, viscosity, and appearance between different production batches and between different manufacturers, making it difficult to effectively guarantee product uniformity and stability. Traditional honey pill preparation processes are crude, with vague key technical parameters and poor scientific rigor.
[0006] Secondly, the lack of content control methods hinders effective quality control of the product. Existing quality standards only include appearance, identification, and routine inspection items (moisture content, weight variation, dissolution time, microbial limits, etc.), without establishing any content determination items. This lack of quantitative control methods for active ingredients such as gallic acid contained in Terminalia chebula pulp in the prescription is problematic. Terminalia chebula pulp is an important component of the prescription, rich in tannins and other active ingredients, including gallic acid. Gallic acid is one of the main bioactive components in Terminalia chebula and a crucial indicator for evaluating the quality of Terminalia chebula medicinal materials and their preparations. Previous studies have established a high-performance liquid chromatography (HPLC) method for the determination of gallic acid in Terminalia chebula. Methodological validation showed good linearity (correlation coefficient of 0.9998) and an average recovery rate of 102.9%. This method is simple, accurate, and can be used for the determination of gallic acid content in preparations containing Terminalia chebula. However, the existing quality standards for Gawazhishixuniz pills have not incorporated this method, making it impossible to effectively control the content of gallic acid in the preparation, which makes it difficult to ensure the uniformity of the content of active ingredients in different batches of products, and also affects the scientific evaluation of the safety and efficacy of the drug.
[0007] Third, there is insufficient research on the traditional honey pill dosage form and a lack of systematic process optimization. Existing technologies lack research reports on the systematic optimization of the preparation process of Gawarishishuniz pills. Scientific experimental design (such as orthogonal experiments) has not been used to screen and verify process parameters such as the ratio of medicinal powder to refined honey, the temperature of the honey mixture, drying time, and drying temperature. The determination of existing process parameters mainly relies on experience, lacking data support and scientific basis, making it impossible to determine the optimal preparation process conditions. Summary of the Invention
[0008] In view of this, the present invention proposes a method for preparing a hair-nourishing and hair-strengthening vitamin B complex to solve the problems existing in the prior art.
[0009] To achieve the above objectives, this invention proposes a method for preparing a hair-nourishing and hair-strengthening vitamin B complex, comprising: According to the weight proportions, 40 parts of black cumin seeds, 40 parts of Terminalia chebula pulp, 80 parts of dried ginger, and 80 parts of Ashoka fruit are crushed and mixed to prepare a mixed medicinal powder. Honey is heated to 105–115°C and refined until its water content is 15%–17% to obtain refined honey. Mix the medicinal ingredients with refined honey at a weight ratio of 1:0.8 to 1:1.3, and control the honey temperature at 50 to 80°C during the mixing process. Stir well to obtain a soft material. The soft material is made into pills; the pills are dried to obtain a hair-nourishing and hair-strengthening medicine, wherein the drying temperature is 50-80℃ and the drying time is 6-12 hours.
[0010] Optionally, the weight ratio of the mixed medicinal powder to refined honey is 1:0.8.
[0011] Optional, the temperature of the honey and herbs is 70℃.
[0012] Optionally, the drying process uses hot air circulation drying; the drying temperature is 70℃; and the drying time is 10 hours.
[0013] On the other hand, the present invention provides a method for optimizing the preparation process parameters of the above-mentioned hair-nourishing and hair-strengthening vitamin B12 medicine, including: Single-factor experiments were conducted to screen the weight ratio of mixed medicinal powder to refined honey, the temperature of the mixed medicinal honey, the drying time, and the drying temperature. Orthogonal experiments were used to comprehensively optimize the three factors of the temperature of the mixed medicinal honey, the drying time, and the drying temperature. The hardness, viscosity, and appearance of the pills were used as evaluation indicators to obtain the optimal preparation process parameters for the hair-nourishing and hair-strengthening medicine.
[0014] On the other hand, the present invention provides a quality control method for the preparation of hair-nourishing and hair-strengthening vitamins, including: The hair-nourishing and hair-strengthening vitamin was extracted with methanol to prepare a test solution, and the content of gallic acid in the test solution was determined by high performance liquid chromatography.
[0015] Optionally, the chromatographic conditions for the high-performance liquid chromatography (HPLC) are as follows: a column packed with octadecylsilane-bonded silica gel, a mobile phase A of phosphoric acid aqueous solution, and a mobile phase B of acetonitrile, with gradient elution and a detection wavelength of 272 nm; the mobile phase A is a 0.1% phosphoric acid solution. The gradient elution program is as follows: 0–20 minutes, mobile phase B from 5% to 10%; 20–40 minutes, mobile phase B from 10% to 30%; 40–50 minutes, mobile phase B from 30% to 5%; 50–60 minutes, mobile phase B at 5%.
[0016] Optionally, the method for preparing the test solution is as follows: Grind the hair-nourishing and hair-strengthening vitamins, add 70% methanol solution, weigh, sonicate, cool, replenish the lost weight, filter, and take the filtrate to obtain the test solution.
[0017] Optionally, high performance liquid chromatography (HPLC) can be used to determine the content of gallic acid in the test solution by obtaining the corresponding chromatogram. In the chromatogram, the external standard method is used to calculate the content of gallic acid in the test solution based on the peak area.
[0018] Compared with the prior art, the beneficial effects of the present invention are as follows: This invention provides an optimized preparation process and quality control method for a hair-nourishing and hair-strengthening herbal medicine. Through single-factor and orthogonal experiments, key process parameters such as the ratio of medicinal powder to refined honey, honey-drying temperature, drying time, and drying temperature were systematically optimized to determine the optimal preparation process. Simultaneously, for the prescription containing Terminalia chebula pulp, a medicinal material rich in gallic acid, a high-performance liquid chromatography (HPLC) method was established to determine the gallic acid content in the Gawarishishunizi pill, achieving accurate control of the gallic acid content. Gallic acid is one of the main bioactive components of Terminalia chebula, with a clear medicinal source and scientific indicator basis. The Gawarishishunizi pill preparation prepared by this invention has a reasonable prescription, accurate process parameters, stable product quality, good processability, and the quality control method has high precision, good stability, good reproducibility, and high recovery rate, effectively controlling product quality and suitable for large-scale industrial production. Attached Figure Description
[0019] Various other advantages and benefits will become apparent to those skilled in the art upon reading the following detailed description of preferred embodiments. The accompanying drawings are for illustrative purposes only and are not intended to limit the invention. In the drawings: Figure 1 This is a flowchart illustrating the preparation process of the hair-nourishing and hair-strengthening vitamin supplement in this embodiment of the invention. Figure 2 This is a bar chart showing the evaluation results of the effect of the ratio of medicinal powder to refined honey on the quality of honey pills in the embodiments of the present invention. Figure 3 This is a graph showing the evaluation results of the effect of honey temperature on the quality of honey pills in an embodiment of the present invention; Figure 4 This is a graph showing the evaluation results of the effect of drying time on the quality of honey pills in an embodiment of the present invention; Figure 5 This is a graph showing the evaluation results of the effect of drying temperature on the quality of honey pills in an embodiment of the present invention; Figure 6 This is a high-performance liquid chromatogram of gallic acid reference standard in the embodiments of the present invention; Figure 7 This is a high-performance liquid chromatogram of the test sample in the embodiments of the present invention; Figure 8 This is a high-performance liquid chromatogram of a negative sample lacking Terminalia chebula pulp in an embodiment of the present invention; Figure 9 This is a standard curve of gallic acid in an embodiment of the present invention; Figure 10 This is a superimposed liquid chromatogram of the recovery rate test in an embodiment of the present invention. Detailed Implementation
[0020] Exemplary embodiments of the present disclosure will now be described in more detail with reference to the accompanying drawings. While exemplary embodiments of the present disclosure are shown in the drawings, it should be understood that the present disclosure may be implemented in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided to enable a more thorough understanding of the present disclosure and to fully convey the scope of the disclosure to those skilled in the art. It should be noted that, unless otherwise specified, the embodiments and features described herein can be combined with each other. The present invention will now be described in detail with reference to the accompanying drawings and embodiments.
[0021] Jiawarixi Xiunizi Wan is a traditional honey pill made from medicinal materials commonly used by the Uyghur people. It is listed in the "Drug Standards of the Ministry of Health of the People's Republic of China: Uyghur Medicine Volume." Its prescription consists of four medicinal materials: black cumin seeds, Terminalia chebula pulp, dried ginger, and Ashoka fruit. The original quality standard only specified a simple preparation method (the medicinal materials are pulverized into a fine powder, mixed with an appropriate amount of refined honey to form pills, and then dried). It lacked clear regulations on key process parameters such as the ratio of medicinal powder to refined honey, the temperature of the honey mixture, drying time, and drying temperature. Furthermore, it did not establish an effective method for content control, making it difficult to guarantee the uniformity and stability of quality across different batches of the product.
[0022] This invention addresses the aforementioned technical problems by providing an optimized preparation process and quality control method for a hair-nourishing and hair-strengthening medicinal product. Through single-factor and orthogonal experiments, this invention systematically optimized key process parameters such as the ratio of medicinal powder to refined honey, honey-drying temperature, drying time, and drying temperature, determining the optimal preparation process. Simultaneously, for the prescription containing Terminalia chebula pulp, a medicinal material rich in gallic acid, a high-performance liquid chromatography (HPLC) method was established to determine the gallic acid content in the Gawarishishunizi pill, achieving accurate control of the gallic acid content. Gallic acid is one of the main bioactive components of Terminalia chebula, with a clearly defined medicinal source and scientifically sound indicators. The Gawarishishunizi pill preparation prepared by this invention has a reasonable prescription, accurate process parameters, stable product quality, good processability, and a high precision, stability, reproducibility, and recovery rate of the quality control method, effectively controlling product quality and suitable for large-scale industrial production.
[0023] The above technical solution is described in detail: To address the shortcomings of the existing technology, the technical problem this invention aims to solve is to provide an optimized preparation process method for a hair-nourishing and hair-strengthening medicine with clearly defined process parameters and stable and controllable product quality, as well as a method for determining the content of gallic acid as an indicator component, so that the preparation process of Gawarishishunizi pills has clear process parameters and controllable product quality. The hair-nourishing and hair-strengthening medicine targeted by this invention is Gawarishishunizi pills.
[0024] This invention provides a method for preparing a hair-nourishing and hair-strengthening medicinal product, as well as an optimization method for the preparation process and a quality control method. This technical solution systematically optimizes the preparation process of Gawarishishunizi pills through single-factor experiments and orthogonal experiments, determining the optimal preparation process parameters. Simultaneously, a high-performance liquid chromatography (HPLC) method using gallic acid as an indicator component is established, achieving quantitative control of the quality of Gawarishishunizi pills.
[0025] This invention provides a method for preparing a hair-nourishing and hair-strengthening vitamin-based medicine. The hair-nourishing and hair-strengthening vitamin-based medicine targeted by this invention is Gawarishishunizi pills, such as... Figure 1 As shown, it includes the following steps: (1) Take the prescribed amount of black cumin seeds, Terminalia chebula pulp, dried ginger and Ashoka fruit, grind them into fine powder, sieve them, mix them evenly to obtain mixed powder; the prescribed amount is 40 parts by weight of black cumin seeds, 40 parts by weight of Terminalia chebula pulp, 80 parts by weight of dried ginger and 80 parts by weight of Ashoka fruit. (2) Take honey, heat and refine it to obtain refined honey; (3) Mix the mixed medicinal powder described in step (1) with the refined honey described in step (2) at a weight ratio of 1:0.8 to 1:1.0, and control the honey temperature at 60 to 80°C when mixing the medicine. Stir evenly to obtain a soft material. (4) The soft material described in step (3) is made into pills; (5) The pills described in step (4) are dried at a temperature of 60-80°C for 8-12 hours to obtain the Gawarishishuniz pills.
[0026] Furthermore, the mesh size of the sieve used in step (1) is 80 to 120 mesh, preferably 100 mesh.
[0027] Furthermore, the refining temperature in step (2) is controlled at 105-115°C, and the water content of the refined honey is controlled at 15%-17%.
[0028] Furthermore, in step (3), the weight ratio of the mixed medicinal powder to the refined honey is 1:0.8, and the temperature of the mixed medicinal honey is 70°C.
[0029] Furthermore, the drying temperature in step (5) is 70°C and the drying time is 10 hours.
[0030] Furthermore, the drying process in step (5) is carried out by hot air circulation drying, vacuum drying or microwave drying, with hot air circulation drying being preferred.
[0031] Furthermore, the weight of each pill in step (4) is 0.5 to 1.0 g.
[0032] The preparation method of the hair-nourishing and hair-strengthening vitamin supplement provided by this invention includes a preparation process optimization method, which specifically includes the following: like Figure 1 As shown, the corresponding preparation method is clearly defined: The prescription composition of the Gawarishishunizi pill of the present invention is as follows: 40 parts by weight of black cumin seeds, 40 parts by weight of Terminalia chebula pulp, 80 parts by weight of dried ginger, and 80 parts by weight of Ashoka fruit.
[0033] Pre-processing of medicinal materials: Take the prescribed amount of black cumin seeds, Terminalia chebula pulp, dried ginger, and Ashoka fruit, grind them into fine powder, sieve them (sieve mesh size of 80-120 mesh, preferably 100 mesh), mix them evenly, and obtain mixed medicinal powder.
[0034] Preparation of refined honey: Take an appropriate amount of honey, heat and refine it, control the refining temperature at 105-115℃, and control the water content of the refined honey at 15%-17%.
[0035] Mixing the medicinal powder and refined honey (medicinal preparation): Mix the above-mentioned medicinal powder and refined honey at a weight ratio of 1:0.8 to 1:1.0, preferably 1:0.8. The honey temperature should be controlled at 60-80℃ during preparation, preferably 70℃. Add the refined honey to the mixed medicinal powder and stir evenly to ensure thorough mixing, thus obtaining a soft material.
[0036] Pelletizing: Place the above-mentioned soft material in a pelletizing machine to make pellets. The specifications of the pellets can be determined as needed, generally with each pellet weighing 0.5 to 1.0g.
[0037] Drying: The prepared pills are dried at a temperature of 60–80°C, preferably 70°C, for a time of 8–12 hours, preferably 10 hours. A hot air circulating drying oven can be used for drying.
[0038] Finished product: After the dried pills pass inspection, the finished product, Gawashishuniz pills, is obtained.
[0039] The above process parameters were determined through the following experimental screening: (1) Single-factor experiment on the ratio of medicinal powder to refined honey: The mixed medicinal powder was divided into four portions, and refined honey was added to each portion at a weight ratio of medicinal powder to refined honey of 1:0.8, 1:1.0, 1:1.2, and 1:1.3, respectively. The mixtures were then formed into pills, dried, and evaluated based on hardness, viscosity, and appearance. Table 1 shows the evaluation criteria for the ratio of medicinal powder to refined honey. Table 1
[0040] Table 2 shows the evaluation results of the ratio of medicinal powder to refined honey. The evaluation results are shown in Table 2: Table 2
[0041] The results showed that the honey pills were of better quality when the ratio of medicinal powder to refined honey was between 1:0.8 and 1:1.0. The highest score (100 points) was achieved when the ratio of medicinal powder to refined honey was 1:0.8. The honey pills had suitable hardness, did not stick to the shell wall, did not stick to the hands, and had a fine and uniform surface, making them of the best quality.
[0042] Combination Figure 2 As shown, the horizontal axis represents the weight ratio of medicinal powder to refined honey (1:0.8, 1:1.0, 1:1.2, 1:1.3), and the vertical axis represents the overall score (out of 100). The highest overall score (100 points) was achieved when the ratio of medicinal powder to refined honey was 1:0.8, resulting in pills with suitable hardness, not sticking to the shell, not sticking to the hand, and with a smooth and uniform surface. The overall score was 80 points for a ratio of 1:1.0, 70 points for 1:1.2, and 60 points for 1:1.3. The results indicate that honey pills of good quality are produced when the ratio of medicinal powder to refined honey is between 1:0.8 and 1:1.0, with 1:0.8 being the optimal ratio.
[0043] (2) Single-factor experiment on the temperature of honey and medicinal herbs: With a fixed ratio of medicinal powder to refined honey of 1:0.8, the mixing temperatures were set at 50℃, 60℃, 70℃, and 80℃ for pill making and drying. The results were evaluated based on hardness, viscosity, and appearance. Table 3 shows the optimized mixing temperature results. Table 3
[0044] Combination Figure 3 As shown, the results indicate that the quality of honey pills is better when the honey temperature is between 60 and 80℃.
[0045] With a fixed ratio of medicinal powder to refined honey of 1:0.8, the pill-making effect was investigated at honey-powder temperatures of 50℃, 60℃, 70℃, and 80℃. At 50℃, the pills were slightly soft, slightly sticky to the shell, and slightly sticky to the hand. At 60℃, 70℃, and 80℃, the pills had suitable hardness, did not stick to the shell, were not sticky to the hand, and had a fine and uniform surface. The results indicate that honey pills made at temperatures between 60℃ and 80℃ have better quality.
[0046] (3) Single-factor experiment on drying time: With a fixed ratio of medicinal powder to refined honey of 1:0.8, the powders were dried at the same temperature for 6, 8, 10, and 12 hours, respectively. The results were evaluated based on hardness, viscosity, and appearance. Table 4 shows the optimized drying time results. Table 4
[0047] Combination Figure 4 As shown, the results indicate that the honey pills have better quality when the drying time is between 8 and 12 hours.
[0048] (4) Single-factor experiment on drying temperature: With a fixed ratio of medicinal powder to refined honey of 1:0.8, the powders were dried at 50℃, 60℃, 70℃, and 80℃ for the same amount of time. The results were evaluated based on hardness, viscosity, and appearance. Table 5 shows the optimized drying temperature results. Table 5
[0049] Combination Figure 5 The results showed that the honey pills scored higher and were of better quality when the drying temperature was between 60 and 70℃.
[0050] (5) Orthogonal experiment optimization: Based on the above single-factor experiments, three factors were selected: honey temperature (A), drying time (B), and drying temperature (C). Three levels were set for each factor, using the L9 (3...) method. 4 Orthogonal experiments were conducted using an orthogonal array, with the appearance, hardness, and viscosity of the honey pills as indicators to screen for the optimal preparation process. Table 7 shows the results for (3) 4 The orthogonal experimental arrangement is shown in Table 7. Table 6 is the preparation process level table, and the level settings of each factor are shown in Table 6. Table 6
[0051] Table 7
[0052] Table 8 shows the screening results of the orthogonal experiment. The results of the orthogonal experiment are shown in Table 8: Table 8
[0053] In orthogonal experiments, the standard definition of K is: the sum of all corresponding experimental results when a factor is at the same level. It is usually denoted by level number K1, K2, K3, etc., corresponding to the cumulative value of all experimental results at level 1, level 2, and level 3. The standard definition of R is: the difference between the maximum and minimum values of K (or k-mean) corresponding to all levels of a factor, also called the range.
[0054] The orthogonal experimental results showed that the order of influence of each factor on the quality of Gawarishishuniz pills was: honey temperature (A) > drying temperature (C) > drying time (B). Based on the K values of each factor, the optimal process combination was selected as A2B2C2, namely, honey temperature of 70℃, drying time of 10 hours, and drying temperature of 70℃.
[0055] The optimized preparation process provided by this invention has the following technical effects: This invention systematically optimized the preparation process of Gawarishishuniz pills through single-factor experiments and orthogonal experiments, and determined the optimal preparation process conditions: the weight ratio of medicinal powder to refined honey is 1:0.8, the temperature of medicinal honey is 70℃, the drying time is 10 hours, and the drying temperature is 70℃.
[0056] Orthogonal experimental results showed that the order of influence of various factors on the quality of Gawazhishixuniz pills was: honey temperature (A) > drying temperature (C) > drying time (B). The honey pills prepared under the optimal process conditions (A2B2C2, i.e., honey temperature 70℃, drying time 10 hours, drying temperature 70℃) achieved the highest overall score (92 points), with a hardness score of 37 points (out of 40), a viscosity score of 27 points (out of 30), and an appearance score of 28 points (out of 30). Compared with other process combinations (the lowest overall score was 60 points), the optimal process improved the overall score by 53.3%, indicating that the preparation process determined in this invention is significantly superior to other process combinations.
[0057] In the single-factor experiment on the ratio of medicinal powder to refined honey, the highest comprehensive score (100 points) was achieved when the ratio was 1:0.8, resulting in pills with suitable hardness, not sticking to the shell wall, not sticking to the hand, and with a fine and uniform surface. However, when the ratio was 1:1.3, the pills were too soft, and the comprehensive score was only 60 points. In the single-factor experiment on the temperature of the medicinal powder and refined honey mixture, pills of good quality were achieved when the temperature was between 60 and 80℃. In the single-factor experiment on drying time, pills of good quality were achieved when the drying time was between 8 and 12 hours. In the single-factor experiment on drying temperature, pills of good quality were achieved when the drying temperature was between 60 and 70℃.
[0058] The above results show that the present invention, through scientific and systematic experimental design, has determined clear process parameters, effectively solving the problems of vague process parameters and unstable product quality in the prior art. The prepared Gawazhisixiuniz pills have suitable hardness, moderate viscosity, and delicate and uniform appearance, and the product quality is significantly improved.
[0059] On the other hand, the preparation method of the hair-nourishing and hair-strengthening vitamin supplement provided by the present invention includes a quality control method, which specifically includes the following: The present invention also provides a quality control method for hair-nourishing and hair-strengthening medicine, which uses gallic acid as an indicator component and employs high performance liquid chromatography (HPLC) to determine the content of gallic acid in Gawarishishuniz pills.
[0060] Specifically, the steps include: taking Gawarishishuniz pills, preparing a test solution, and determining the content of gallic acid in the test solution using high performance liquid chromatography; The chromatographic conditions for the high-performance liquid chromatography method are as follows: Column: Octadecylsilane-bonded silica column (ACE Super C18-Amide column, C 18 The column has a specification of 4.6mm×250mm and 5μm, preferably ACE SuperC18-Amide column (250mm×4.6mm, S-5μm, 12nm). Mobile phase: A is 0.1% phosphoric acid solution, B is acetonitrile, gradient elution, the gradient elution program is as follows: The gradient elution program is as follows: 0–20 min, 5% → 10% B; 20–40 min, 10% → 30% B; 40–50 min, 30% → 5% B; 50–60 min, 5% B.
[0061] Specifically, this gradient program runs for 60 minutes, with an initial ratio of 95% mobile phase A and 5% mobile phase B; after 20 minutes, A decreases to 90% and B increases to 10%; after 40 minutes, A continues to decrease to 70% and B increases to 30%; then, between 40 and 50 minutes, the ratio quickly returns to the initial 95% A and 5% B; finally, it maintains this initial ratio for 50 to 60 minutes. Flow rate: 0.8–1.2 mL / min, preferably 1.0 mL / min; Detection wavelength: 266–273 nm, preferably 272 nm; Column temperature: 25–35℃, preferably 30℃; Injection volume: 10–20 μL, preferably 20 μL.
[0062] Under the above chromatographic conditions, gallic acid and other component chromatographic peaks reach baseline separation, and the theoretical plate number calculated based on the gallic acid peak should be no less than 3000.
[0063] Preparation of the reference solution: Accurately weigh an appropriate amount of gallic acid reference standard and add methanol to prepare a reference standard stock solution containing 0.5 mg of gallic acid per 1 mL. Accurately measure an appropriate amount of the reference standard stock solution and dilute it with methanol to prepare a reference standard solution containing 20–70 μg of gallic acid per 1 mL.
[0064] Preparation of the test solution: Take an appropriate amount of Gawazhishixuniz pills, grind them into a fine powder, take about 0.5-1.0g of the powder, weigh it accurately, place it in a stoppered conical flask, accurately add 25-50mL of 70% methanol solution, seal tightly, weigh it, sonicate for 30-60 minutes, cool, weigh it again, make up the lost weight with 70% methanol, shake well, filter, and take the filtrate as the test solution.
[0065] Preferably, the preparation method of the test solution is as follows: take Gawazhishixuniz pills, grind them into a fine powder, take about 0.5g of the powder, weigh it accurately, place it in a stoppered conical flask, accurately add 25mL of 70% methanol, seal tightly, weigh it, sonicate for 30 minutes, cool, weigh it again, replenish the lost weight with 70% methanol, shake well, filter, and take the filtrate as the test solution.
[0066] Measurement method: Accurately pipette 10–20 μL each of the reference solution and the test solution into the liquid chromatograph, determine the chromatogram under the chromatographic conditions described above, record the chromatogram, and calculate the content of gallic acid in the test solution by peak area using the external standard method.
[0067] Validation of assay method: (1) Linearity investigation: An appropriate amount of gallic acid reference solution was accurately measured and diluted with methanol to prepare a series of reference solutions of different concentrations. These solutions were then injected and analyzed under the chromatographic conditions described above. A standard curve was plotted with the gallic acid concentration (μg / mL) as the abscissa (X) and the peak area as the ordinate (Y). The results showed that gallic acid exhibited a good linear relationship with its peak area within the concentration range of 19.96–69.88 μg / mL. The regression equation was Y = 34607x + 12415, and the correlation coefficient R0 was [value missing]. 2 =0.999.
[0068] (2) Specificity test: The reference solution, the test solution, and the negative sample solution lacking Terminalia chebula pulp were injected and analyzed under the above chromatographic conditions. The results showed that the test sample chromatogram showed the same chromatographic peak at the corresponding position as the gallic acid reference chromatogram, while the negative sample showed no interfering peak at this position, indicating that the method has good specificity.
[0069] (3) Precision test: Take the test solution and inject it 6 times consecutively under the above chromatographic conditions. Record the peak area of gallic acid and calculate the RSD value. The result shows that the RSD value is less than 2%, which indicates that the instrument has good precision.
[0070] (4) Stability test: The test solution was placed at room temperature for 0, 3, 6, 9, 12, 15, 18, 21 and 24 hours for analysis. The gallic acid peak area was recorded and the RSD value was calculated. The results showed that the test solution had good stability within 24 hours, and the RSD value was less than 2%.
[0071] (5) Repeatability test: Six samples of the same batch of Gawashishuniz pills were taken, and test solutions were prepared according to the test solution preparation method. The samples were injected and determined under the above chromatographic conditions, and the gallic acid content and its RSD value were calculated. The results showed that the RSD value was less than 3%, indicating that the method had good repeatability.
[0072] (6) Recovery test: Approximately 0.25 g of the known content of the gallic acid sample powder was accurately weighed into 9 portions. Gallic acid reference solution was added to the samples at three levels: low, medium, and high. The samples were prepared according to the method for preparing the test solution and injected under the chromatographic conditions described above. The recovery rate was calculated. The results showed that the average recovery rate of gallic acid was 104%–110%, and the RSD value was less than 2%, indicating that the method was accurate.
[0073] (7) Limit of detection and limit of quantitation: Gallic acid reference solution was serially diluted with methanol and injected for determination under the above chromatographic conditions. The limit of detection was the concentration corresponding to a signal-to-noise ratio (S / N) of 3:1, and the limit of quantitation was the concentration corresponding to a signal-to-noise ratio (S / N) of 10:1. The results showed that the limit of detection of gallic acid was 0.20 μg / mL, and the limit of quantitation was 1.00 μg / mL.
[0074] Content limit: Based on the test results of multiple batches of samples, it is tentatively determined that the total amount of gallic acid in each gram of Gawarishishuniz pill is not less than 5.0 μg.
[0075] like Figure 6 As shown, the horizontal axis represents retention time (minutes), and the vertical axis represents the response value (mAU). Gallic acid reference standard exhibits a single, symmetrical chromatographic peak at approximately 15.2 minutes at a detection wavelength of 272 nm, with a good peak shape and no interference from impurity peaks. This chromatogram indicates that the purity of the reference solution meets the requirements and can be used for quantitative analysis.
[0076] like Figure 7 As shown, the horizontal axis represents retention time (minutes), and the vertical axis represents the response value (mAU). The test sample chromatogram exhibits the same chromatographic peak at the corresponding retention time (approximately 15.2 minutes) as the gallic acid reference standard chromatogram, and this peak achieves baseline separation from adjacent peaks with a resolution greater than 1.5. Other components in the test sample do not interfere with the quantitative determination of gallic acid.
[0077] like Figure 8 As shown, the horizontal axis represents retention time (minutes), and the vertical axis represents the response value (mAU). In the chromatogram of the negative sample lacking Terminalia chebula pulp, no chromatographic peak appeared at the retention time corresponding to the gallic acid reference standard (approximately 15.2 minutes). This result indicates that other medicinal materials in the prescription (nigcum seed, dried ginger, and Ayurvedic fruit) do not interfere with the determination of gallic acid, and the method has good specificity.
[0078] like Figure 9 As shown, the x-axis represents the gallic acid concentration (μg / mL), and the y-axis represents the peak area. A linear regression was performed with gallic acid concentration as the x-axis (X) and peak area as the y-axis (Y), and the standard curve showed a good linear relationship. The regression equation is Y = 34607X + 12415, and the correlation coefficient R0 is [value missing].2 =0.999. Gallic acid showed good linearity in the concentration range of 19.96–69.88 μg / mL.
[0079] like Figure 10 As shown in the figure, the HPLC overlay plots of 50% spiked test solutions (2, 3, 4), 100% spiked test solutions (5, 6, 7), and 150% spiked test solutions (8, 9, 10) are displayed. At each spike level, the peak area of gallic acid (approximately 8.5 min) increases proportionally with increasing spike concentration, and the peak shape is good with no interference from impurities, indicating good method accuracy. The average recovery rate at the low level (50% spike) was 110.22%, RSD = 5.09%; the average recovery rate at the medium level (100% spike) was 104.45%, RSD = 3.01%; and the average recovery rate at the high level (150% spike) was 105.73%, RSD = 3.20%.
[0080] The quality control provided by this invention pertains to content determination methods, and the relevant results of the content determination are as follows: This invention establishes for the first time a high-performance liquid chromatography (HPLC) method for the determination of gallic acid content in Gavarisshuniz pills, using gallic acid as an indicator component. The methodological validation results are as follows: 1. Linearity: Gallic acid showed a good linear relationship with its peak area within the concentration range of 19.96–69.88 μg / mL. The regression equation was Y = 34607X + 12415, and the correlation coefficient R0 was [value missing]. 2 =0.999, indicating that the method has a good linear response within the measurement range.
[0081] 2. Specificity: The test sample showed the same chromatographic peak at the corresponding position as the gallic acid reference standard in the chromatogram. The negative sample lacking Terminalia chebula pulp did not show any interfering peak at this position, indicating that other components in the prescription did not interfere with the determination of gallic acid, and the method has good specificity.
[0082] 3. Precision: The average gallic acid content was 32.59 μg / mL after 6 consecutive injections of the test solution, with an RSD of 1.90% (n=6), indicating that the instrument has good precision.
[0083] 4. Stability: The test solution was sampled and measured at room temperature for 3, 6, 9, 12, 15, 18, 21 and 24 hours. The RSD of the content at each time point was 1.63%, indicating that the test solution had good stability within 24 hours.
[0084] 5. Spiking recovery rates: The average recovery rate for the low level (50% spike) was 110.22%, with an RSD of 5.09%; the average recovery rate for the medium level (100% spike) was 104.45%, with an RSD of 3.01%; and the average recovery rate for the high level (150% spike) was 105.73%, with an RSD of 3.20%. The average spiking recoveries for all three levels were between 104% and 110%, and the RSD values were all less than 6%, indicating good method accuracy.
[0085] 6. Limit of detection and limit of quantitation: The limit of detection for gallic acid was 0.20 μg / mL, and the limit of quantitation was 1.00 μg / mL, indicating that the method has high sensitivity for gallic acid in Gawashishuniz pills.
[0086] The above methodological validation results show that the content determination method established in this invention has strong specificity, high precision (RSD < 2%), good stability (RSD < 2% within 24 hours), good reproducibility, and high recovery rate (104% ~ 110%). All indicators meet the requirements for the validation of analytical methods for drug quality standards and can be effectively used for the quality control of Gawarishishuniz pills.
[0087] The working principle of the technical solution of this invention is as follows: This invention systematically screened and optimized key parameters (ratio of medicinal powder to refined honey, temperature of mixing with honey, drying time, and drying temperature) in the preparation process of Gawarishishuniz pills through single-factor experiments and orthogonal experiments. The ratio of medicinal powder to refined honey directly affects the shapeability and hardness of the pills. Too high a ratio (too much refined honey) will result in pills that are too soft and too sticky, while too low a ratio (too little refined honey) will result in pills that are too hard and difficult to shape. The temperature of mixing with honey affects the uniformity and plasticity of the mixing of medicinal powder and refined honey. If the temperature is too low, the honey will be too viscous and difficult to mix evenly, while if the temperature is too high, it may destroy the active ingredients in the honey. The drying temperature and drying time affect the final hardness, moisture content, and appearance quality of the pills. Too low a temperature or too short a time will result in pills with high moisture content and easy mold growth, while too high a temperature or too long a time will result in pills that are too hard and affect disintegration and dissolution.
[0088] This invention establishes a high-performance liquid chromatography (HPLC) method for content determination, using gallic acid as the indicator component. Gallic acid is one of the main active ingredients in Terminalia chebula pulp of the prescription, and selecting gallic acid as the content determination indicator has a clear basis in terms of the source of the medicinal material and a scientific basis for the indicator component. C1 18 The chromatographic column, phosphoric acid-acetonitrile gradient elution, and 272nm UV detection enable good separation of gallic acid from other components. The method is highly specific, precise, reproducible, and has a high recovery rate, which can effectively control the product quality of Gawazhishixuniz pills.
[0089] In summary, the present invention has the following comprehensive technical effects: Process parameters were clarified: Through single-factor experiments and orthogonal experiments, the original vague process parameters such as "adding an appropriate amount of refined honey" and "drying" were clarified into specific quantitative indicators (the ratio of medicinal powder to refined honey is 1:0.8, the temperature of the medicinal honey is 70℃, the drying time is 10 hours, and the drying temperature is 70℃), which realized the standardization and controllability of the preparation process and is conducive to large-scale industrial production.
[0090] Product quality controllability: An HPLC method for determining the content of gallic acid as an indicator component was established, which enabled quantitative control of the active ingredients in Gawarishishuniz pills. This method compensates for the lack of content determination items in existing quality standards and can effectively ensure the uniformity of active ingredient content in different batches of products.
[0091] High efficiency of detection method: The HPLC content determination method established in this invention is simple to operate, fast to analyze (analysis time for a single sample is about 60 minutes), and accurate and reliable. It is suitable for the daily quality control detection of Gawarishishuniz pills and has good prospects for promotion and application.
[0092] Scientific Standardization: This invention provides a scientific basis and technical support for improving the quality standards of Gawarishishuniz pills, and has positive significance for promoting the standardization and modernization of Uyghur medicine preparations.
[0093] Example 6: Content determination of three batches of samples Three batches of gallic acid pills prepared according to the method in Example 1 were taken, and test solutions were prepared according to the method in Example 4. The solutions were then injected and analyzed under the chromatographic conditions described in Example 4, and the gallic acid content was calculated. Table 9 shows the content determination results of the three batches of samples.
[0094] Table 9
[0095] As shown in Table 9, the results show that the content of gallic acid in the three batches of samples is uniform and the RSD value is less than 3%, indicating that the preparation process of the present invention is stable and the product quality is controllable.
[0096] Example 7: Examination of Gawazhishixuniz pills The examination was conducted according to the methods described in Section 0108, Pills, of the General Rules for Preparations, Part IV, of the 2020 edition of the Chinese Pharmacopoeia.
[0097] (1) Moisture Take this product and determine its moisture content according to the method for determination of moisture content (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 0832, Method II). The result should meet the requirements (not exceeding 15.0%).
[0098] (2) Weight difference Take this product and test it according to the method for testing the weight difference of pills (General Chapter 0108, Part IV, Chinese Pharmacopoeia 2020 Edition). The results should meet the requirements.
[0099] (3) Dissolution time Take this product and test it according to the disintegration time test method (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 0921). The small honey pills should completely dissolve within 1 hour. The results should meet the requirements.
[0100] (4) Microbial limits Test according to the microbial limit test method (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapters 1105, 1106, and 1107). The total aerobic bacterial count should not exceed 10. 4 cfu / g, total mold and yeast count must not exceed 10. 2 The cfu / g level should be within acceptable limits; Escherichia coli should not be detected, and Salmonella should not be detected per 10g. Results should meet the requirements.
[0101] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit it. Although the present invention has been described in detail with reference to the above embodiments, those skilled in the art should understand that modifications or equivalent substitutions can still be made to the specific implementation of the present invention. Any modifications or equivalent substitutions that do not depart from the spirit and scope of the present invention should be covered within the scope of protection of the claims of the present invention.
Claims
1. A method for preparing a hair-nourishing and hair-strengthening vitamin, characterized in that, include: According to the weight proportions, 40 parts of black cumin seeds, 40 parts of Terminalia chebula pulp, 80 parts of dried ginger, and 80 parts of Ashoka fruit are crushed and mixed to prepare a mixed medicinal powder. Honey is heated to 105–115°C and refined until its water content is 15%–17% to obtain refined honey. Mix the medicinal powder with refined honey at a weight ratio of 1:0.8 to 1:1.3, and control the honey temperature at 50 to 80°C during the mixing process. Stir well to obtain a soft material. The soft material is made into pills; the pills are dried to obtain a hair-nourishing and hair-strengthening medicine, wherein the drying temperature is 50-80℃ and the drying time is 6-12 hours.
2. The preparation method according to claim 1, characterized in that, The weight ratio of the mixed medicinal powder to refined honey is 1:0.
8.
3. The preparation method according to claim 1, characterized in that, The temperature of the honey and herbs should be 70℃.
4. The preparation method according to claim 1, characterized in that, The drying process uses hot air circulation drying; the drying temperature is 70℃; and the drying time is 10 hours.
5. The method for optimizing the preparation process parameters of the hair-nourishing and hair-strengthening vitamin B complex according to any one of claims 1-4, characterized in that, include: Single-factor experiments were conducted to screen the weight ratio of mixed medicinal powder to refined honey, the temperature of the mixed medicinal honey, the drying time, and the drying temperature. Orthogonal experiments were used to comprehensively optimize the three factors of the temperature of the mixed medicinal honey, the drying time, and the drying temperature. The hardness, viscosity, and appearance of the pills were used as evaluation indicators to obtain the optimal preparation process parameters for the hair-nourishing and hair-strengthening medicine.
6. A quality control method for the preparation of the hair-nourishing and hair-strengthening vitamin B complex according to any one of claims 1-4, characterized in that, include: The hair-nourishing and hair-strengthening vitamin was extracted with methanol to prepare a test solution, and the content of gallic acid in the test solution was determined by high performance liquid chromatography.
7. The quality control method according to claim 6, characterized in that, The chromatographic conditions for the high-performance liquid chromatography (HPLC) method are as follows: a column packed with octadecylsilane-bonded silica gel, mobile phase A of phosphoric acid aqueous solution, and mobile phase B of acetonitrile, with gradient elution and a detection wavelength of 272 nm; mobile phase A is a 0.1% phosphoric acid solution. The gradient elution program is as follows: 0–20 minutes, mobile phase B from 5% to 10%; 20–40 minutes, mobile phase B from 10% to 30%; 40–50 minutes, mobile phase B from 30% to 5%; 50–60 minutes, mobile phase B at 5%.
8. The quality control method according to claim 6, characterized in that, The method for preparing the test solution is as follows: Grind the hair-nourishing and hair-strengthening vitamins, add 70% methanol solution, weigh, sonicate, cool, replenish the lost weight, filter, and take the filtrate to obtain the test solution.
9. The quality control method according to claim 6, characterized in that, The chromatogram was recorded during the determination using high performance liquid chromatography. In the chromatogram, the content of gallic acid in the test solution was calculated by peak area using the external standard method.
